Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

Straumann H1 earnings miss market expectations

Published by Global Banking and Finance Review

Posted on August 13, 2025

Featured image for article about Finance

(Reuters) -Swiss dental implant maker Straumann on Wednesday reported first half earnings which were below market expectations and warned macroeconomic uncertainties were expected to persist.

The company, which specialises in tooth replacement and orthodontic solutions, reported core earnings before interest and taxes (EBIT) of 358 million francs in the first half, slightly below consensus estimates of 365 million francs.

Its sales grew to 1.35 billion Swiss francs ($1.67 billion)in the period, broadly in line with analysts' expectations of 1.36 billion francs in a Vara consensus.

Straumann confirmed its 2025 sales forecast, saying it aims to achieve organic revenue growth in the high single-digit percentage range.

The company said while macroeconomic uncertainties, including rising trade tariffs and regional demand fluctuations are expected to persist, its "strong fundamentals" provided resilience.

Straumann has shown resilience to changing U.S. tariff policies as 80% of the products it sells in the United States are manufactured domestically.

($1 = 0.8063 Swiss francs)

(Reporting by Cian Muenster and Bartosz Dabrowski in Gdansk)